Who owns ANI PHARMACEUTICALS INC?
- CUSIP Number: 00182cac7
Tip: Access positions for across all investors
Analyze quarterly positions in Ani Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ani Pharmaceuticals stock
Who bought or sold ANI PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 71M | $100M | 100% | Sep 2025 |
|
| Camden Asset Management | 38M | $53B | 100% | Sep 2025 |
|
| BlackRock | 28M | $39M | 100% | Sep 2025 |
|
| Empyrean Capital Partners | 23M | $32M | 100% | Sep 2025 |
|
| Millennium Management | 21M | $30M | 100% | Sep 2025 |
|
| Citadel Advisors | 20M | $27M | 100% | Sep 2025 |
|
| Absolute Investment Advisers | 12M | $16M | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 9.3M | $13M | 100% | Sep 2025 |
|
| Lazard Asset Management | 7.9M | $111k | 100% | Sep 2025 |
|
| Polar Securities | 6.0M | $8.4M | 100% | Sep 2025 |
|
| Gabelli Funds | 5.1M | $7.1M | 100% | Sep 2025 |
|
| Leucadia National Corporation | 4.5M | $6.3M | 100% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 4.1M | $5.8M | 100% | Sep 2025 |
|
| Picton Mahoney Asset Management | 4.0M | $5.6M | 100% | Sep 2025 |
|
| FMR | 2.6M | $3.6M | 100% | Sep 2025 |
|
| Jain Global | 2.5M | $3.5M | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.1M | $1.6M | 100% | Sep 2025 |
|
| Bank of New York Mellon | 700k | $984k | 100% | Sep 2025 |
|
| Jane Street | 50k | $71k | 100% | Sep 2025 |
|
| Calamos Advisors | 29k | $41k | 100% | Sep 2025 |
|
| Boussard & Gavaudan Investment Management | 10k | $14M | 100% | Sep 2025 |
|